Brady Dougan graduated with a B.A. in Economics from the University of Chicago and an MBA in Finance from the Booth School of Business. In 1982, he began his career in the derivatives group at Bankers Trust and later joined Credit Suisse First Boston in 1990. He became the Head of the Equities division in 1996 and five years later was appointed the Global Head of the Securities division. From 2002-2004, he was the Co-President of Institutional Services at Credit Suisse First Boston and became CEO of the company in 2004. After the merger of Credit Suisse and Credit Suisse First Boston in 2005, he was named CEO of the Investment Banking division. In 2007, Brady was named CEO of Credit Suisse. He currently serves on the Board of Trustees at the University of Chicago as well as the Board of Directors of Humacyte, a biotechnology company.